Junqing Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 8
- RNA Research and Splicing 5
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 3
- Gene expression and cancer classification 2
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 4
- Co-authors
- Xuehua Chen (8 shared papers)Zhenggang Zhu (7 shared papers)Xiaochun Fei (9 shared papers)Bingya Liu (5 shared papers)Liping Su (5 shared papers)Qu Cai (4 shared papers)Pu Li (4 shared papers)Fengjie Hao (7 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Anti-Cancer Drugs (2 papers)Oncotarget (2 papers)Molecular Medicine (1 paper)Frontiers of Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Junqing Wang
30 papers receiving 563 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 308
- Molecular Biology 362
- Biochemistry 29
- Oncology 81
- Pulmonary and Respiratory Medicine 49
Countries citing papers authored by Junqing Wang
This map shows the geographic impact of Junqing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqing Wang more than expected).
Fields of papers citing papers by Junqing Wang
This network shows the impact of papers produced by Junqing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqing Wang. The network helps show where Junqing Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junqing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 141 | |
| 2 | SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c. | 2019 | 46 |
| 3 | 2013 | 40 | |
| 4 | 2023 | 37 | |
| 5 | 2018 | 36 | |
| 6 | 2017 | 23 | |
| 7 | 2013 | 23 | |
| 8 | 2020 | 20 | |
| 9 | 2020 | 18 | |
| 10 | 2016 | 18 | |
| 11 | 2020 | 18 | |
| 12 | 2016 | 16 | |
| 13 | 2015 | 16 | |
| 14 | 2017 | 12 | |
| 15 | 2023 | 11 | |
| 16 | 2020 | 11 | |
| 17 | 2022 | 11 | |
| 18 | Positive feedback loop of AKR1B10P1/miR-138/SOX4 promotes cell growth in hepatocellular carcinoma cells. | 2020 | 10 |
| 19 | 2012 | 10 | |
| 20 | 2017 | 10 |
About Junqing Wang
Junqing Wang is a scholar working on Molecular Biology, Cancer Research, Cell Biology, Oncology and Surgery, having authored 31 papers that have together received 567 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers), RNA Research and Splicing (5 papers), Epigenetics and DNA Methylation (4 papers), MicroRNA in disease regulation (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Circular RNAs in diseases (3 papers) and Gene expression and cancer classification (2 papers). The work is most often cited by research in Cancer Research (308 citations), Molecular Biology (362 citations), Biochemistry (29 citations), Oncology (81 citations) and Pulmonary and Respiratory Medicine (49 citations). Junqing Wang has collaborated with scholars based in China and United States. Frequent co-authors include Xuehua Chen, Zhenggang Zhu, Xiaochun Fei, Bingya Liu, Liping Su, Qu Cai, Pu Li, Fengjie Hao, Yongjun Chen and Beiqin Yu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Anti-Cancer Drugs, Oncotarget, Molecular Medicine and Frontiers of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.